MX9301627A - Agente para utilizarse como un antiirritante y composicion que lo contiene. - Google Patents

Agente para utilizarse como un antiirritante y composicion que lo contiene.

Info

Publication number
MX9301627A
MX9301627A MX9301627A MX9301627A MX9301627A MX 9301627 A MX9301627 A MX 9301627A MX 9301627 A MX9301627 A MX 9301627A MX 9301627 A MX9301627 A MX 9301627A MX 9301627 A MX9301627 A MX 9301627A
Authority
MX
Mexico
Prior art keywords
pct
date sep
irritant
agent
containing composition
Prior art date
Application number
MX9301627A
Other languages
English (en)
Inventor
Gerard Frans Maria Cauwenbergh
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9301627A publication Critical patent/MX9301627A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

EL uso de un compuesto que tiene la fórmula (I), o una forma de sal ácida de adición cosméticamente aceptable del mismo, para evitar o reducir irritación o comezón de la piel de seres humanos; composiciones cosméticas que comprenden duchos agentes, procedimientos para preparar dichas composiciones, y un método para evitar o reducir la irritación o comezón de la piel en seres humanos.
MX9301627A 1992-03-23 1993-03-23 Agente para utilizarse como un antiirritante y composicion que lo contiene. MX9301627A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200828 1992-03-23

Publications (1)

Publication Number Publication Date
MX9301627A true MX9301627A (es) 1994-07-29

Family

ID=8210497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301627A MX9301627A (es) 1992-03-23 1993-03-23 Agente para utilizarse como un antiirritante y composicion que lo contiene.

Country Status (18)

Country Link
US (1) US5476853A (es)
EP (1) EP0632717B1 (es)
JP (1) JPH07504905A (es)
KR (1) KR100234627B1 (es)
AT (1) ATE168004T1 (es)
AU (1) AU665816B2 (es)
CA (1) CA2132528C (es)
CY (1) CY2133B1 (es)
DE (1) DE69319589T2 (es)
DK (1) DK0632717T3 (es)
ES (1) ES2118255T3 (es)
HK (1) HK1010343A1 (es)
IL (1) IL105122A (es)
MX (1) MX9301627A (es)
SG (1) SG48748A1 (es)
TW (1) TW248530B (es)
WO (1) WO1993018744A1 (es)
ZA (1) ZA932025B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403451D0 (en) * 1994-02-23 1994-04-13 Ciba Geigy Ag Sunscreen compositions
US5614511A (en) * 1996-03-11 1997-03-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for treating itchy skin
US5670142A (en) * 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox
AU753270B2 (en) * 1998-05-21 2002-10-10 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
MY134575A (en) * 2000-09-28 2007-12-31 Uni Charm Corp Absorbent article and barrier agent for absorbent article
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
EP2919773A4 (en) * 2012-11-19 2016-11-02 Univ Columbia METHOD FOR THE TREATMENT OF KERATINOCYTE-MEDIATED LESIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
DE2436883C2 (de) * 1974-07-29 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
YU39992B (en) * 1976-04-02 1985-06-30 Janssen Pharmaceutica Nv Process for obtaining new piperazine and piperidine derivatives
US4250176A (en) * 1976-12-21 1981-02-10 Janssen Pharmaceutica N.V. Piperazine derivatives
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4377578A (en) * 1976-12-21 1983-03-22 Janssen Pharmaceutica, N.V. Piperazine derivatives
ZA914764B (en) * 1990-06-22 1992-03-25 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene,piperidylidene and piperazine compounds,compositions and methods of use
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
IL105122A0 (en) 1993-07-08
AU665816B2 (en) 1996-01-18
HK1010343A1 (en) 1999-06-17
CA2132528A1 (en) 1993-09-30
AU3749893A (en) 1993-10-21
EP0632717A1 (en) 1995-01-11
SG48748A1 (en) 1998-05-18
WO1993018744A1 (en) 1993-09-30
KR950700050A (ko) 1995-01-16
DE69319589T2 (de) 1998-11-26
JPH07504905A (ja) 1995-06-01
DK0632717T3 (da) 1999-02-22
TW248530B (es) 1995-06-01
DE69319589D1 (de) 1998-08-13
ZA932025B (en) 1994-09-22
EP0632717B1 (en) 1998-07-08
CY2133B1 (en) 2002-06-21
ES2118255T3 (es) 1998-09-16
KR100234627B1 (ko) 1999-12-15
US5476853A (en) 1995-12-19
ATE168004T1 (de) 1998-07-15
CA2132528C (en) 2004-06-08
IL105122A (en) 1998-06-15

Similar Documents

Publication Publication Date Title
ES2052061T3 (es) Composicion anestesica hidratante de la piel y metodo para preparar la misma.
DE69104723T2 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
KR930702954A (ko) 조성물
OA09877A (fr) Compositions cosmétiques contenant un extrait d'eclipta alba
SE8303732D0 (sv) Compositon for reducing sebum secretion
MX9301627A (es) Agente para utilizarse como un antiirritante y composicion que lo contiene.
ATE76287T1 (de) Filmbildendes mittel zur topischen anwendung.
GB1583211A (en) Permanent wawing
DE69315836T2 (de) Pyrazolpyridine für die behandlung der anämie
ZA944245B (en) Use of cobalamine for topical treatment of dermatological illnesses.
KR920700627A (ko) 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도
AU6250680A (en) Phosphono-hydroxy-acetic acid
TR199801398T2 (xx) Ast�m� tedavi edici maddeler
KR950703341A (ko) 항부정맥제
ATE428409T1 (de) Abgabesysteme für aktive bestandteile die eine salicylsäurederivat-zusammensetzung auf einem film enthalten und ihre verwendung
KR930701976A (ko) 알칸 아미도 암모늄 화합물의 신규용도
NZ323980A (en) Antiseptic composition containing a quaternary ammonium compound, a chelating agent and a polyol
DK0409302T3 (da) Kosmetiske præparater
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
ATE120464T1 (de) Acylaminoalkylidenhydroxybisphosphonsäure brauchbar in der therapie von osteoartikularen krankheiten.
JPS5788108A (en) Cosmetic
JPS649906A (en) External drug for skin
ATE4204T1 (de) 2-(2-chlor-4-cyclopropyl-phenyl-imino)imidazolidin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.